Generation of glucose-sensitive insulin-secreting beta-like cells from human embryonic stem cells by incorporating a synthetic lineage-control network

• Published in: Journal of biotechnology 2017-10, Vol.259, p.39-45
• Main Authors: Saxena, Pratik, Bojar, Daniel, Zulewski, Henryk, Fussenegger, Martin
• Format: Article
• Language: English
• Subjects: Cell Line; Gene Regulatory Networks - genetics; Gene switch; Glucose - metabolism; Human Embryonic Stem Cells - cytology; Human Embryonic Stem Cells - metabolism; Humans; Insulin - metabolism; Insulin Secretion; Insulin-Secreting Cells - cytology; Insulin-Secreting Cells - metabolism; Lineage-control network; Stem cells; Synthetic biology; Synthetic Biology - methods; Transcription Factors - genetics; Transcription Factors - metabolism
• ISSN: 0168-1656; 1873-4863
• DOI: 10.1016/j.jbiotec.2017.07.018

•A synthetic lineage-control network was inserted into human embryonic stem cells.•It mimicked physiological expression dynamics of transcription factors Ngn3/Pdx1/MafA.•Activation with vanillic acid induced differentiation to functional beta-like cells.•Network-induced beta-like cells secreted insulin in response to elevated glucose. We previously reported novel technology to differentiate induced pluripotent stem cells (IPSCs) into glucose-sensitive insulin-secreting beta-like cells by engineering a synthetic lineage-control network regulated by the licensed food additive vanillic acid. This genetic network was able to program intricate expression dynamics of the key transcription factors Ngn3 (neurogenin 3, OFF-ON-OFF), Pdx1 (pancreatic and duodenal homeobox 1, ON-OFF-ON) and MafA (V-maf musculoaponeurotic fibrosarcoma oncogene homologue A, OFF-ON) to guide the differentiation of IPSC-derived pancreatic progenitor cells to beta-like cells. In the present study, we show for the first time that this network can also program the expression dynamics of Ngn3, Pdx1 and MafA in human embryonic stem cell (hESC)-derived pancreatic progenitor cells and drive differentiation of these cells into glucose-sensitive insulin-secreting beta-like cells. Therefore, synthetic lineage-control networks appear to be a robust methodology for differentiating pluripotent stem cells into somatic cell types for basic research and regenerative medicine.